
Hosted by Taking The Pulse · EN

This episode, Heather and Matthew welcome attorney John Erwin, the newest addition to Maynard Nexsen’s Health Care and Life Sciences team, to discuss the landscape of mergers and acquisitions in the life sciences industry. John shares insight from his decades of experience in complex healthcare and life sciences transactions, including how data considerations and emerging technologies are shaping deal activity. We also discuss regions like North Carolina’s Research Triangle that continue to attract investment. Tune in for a look at how transactional strategy is adapting and what may lie ahead for life sciences over the next year!

Hosts Heather and Lauren are joined by Leslie Isenhour, Dean of Biotechnologies and North Carolina BioNetwork Capstone Center at Wake Tech Community College. With the growing demand for life sciences talent in North Carolina, Dean Isenhour shares how Wake Take is preparing the community through customized training programs, apprenticeships, and early exposure at the high school level. We discuss what draws major companies to the region and how community colleges partner with industry to close skill gaps, as well as the role of workforce development in supporting continued growth in biopharmaceutical manufacturing. Tune in to hear how education, infrastructure, and community investment come together to build a strong and sustainable talent pipeline in North Carolina!

Recorded at the SCbio Annual Conference, hosts Heather and Lauren welcome John Balchunas, Workforce Director at the National Institute for Innovation in Manufacturing Biopharmaceuticals, known as NIIMBL. John shares insight into how the life sciences industry is approaching workforce and talent development at a national level. The conversation explores challenges facing the biopharmaceutical manufacturing workforce, the growing influence of automation and AI, and why skills based hiring and regional cooperation will play an important role in building a sustainable talent pipeline. Tune in for a look at how organizations are working to future-proof the workforce behind advanced manufacturing and life sciences innovation!

Recorded at the 2026 SCbio Annual Conference in Charleston, Heather and Matthew are joined by Dr. Besim Ogretmen, an internationally recognized cancer researcher at MUSC and Co-Founder and CEO of Lipo‑Immuno Tech. Dr. Ogretmen shares how his team is developing novel chemoimmunotherapy approaches designed to enhance immune cell function and improve outcomes for patients with advanced cancers. We also discussed building a biotech company from academic research, securing non‑dilutive funding, scaling manufacturing, and leveraging AI to support research and regulatory efforts. Tune in for an inside look at how their unique treatments are changing and extending patients’ lives!

Heather and Matthew welcome Christin Carey, Maynard Nexsen’s newest FDA‑focused life sciences attorney, for a discussion on regulatory developments shaping the life sciences and digital health industries. Drawing on her extensive experience advising companies on FDA compliance and her recent in‑house role at Amazon Health Services, Christin shares insight on new tariffs affecting pharma and biotech, evolving FDA guidance for digital health and clinical decision support tools, and the agency’s approach to AI, cybersecurity, and emerging technologies. Tune in for valuable guidance on navigating FDA regulation while developing innovative health products.

Recorded at the 2026 SCbio Annual Conference, Heather and Matthew are joined by Dr. Joseph Scalea, a nationally recognized transplant surgeon, academic leader, and healthcare innovator. Dr. Scalea shares his perspective on caring for patients facing life‑altering transplants, including the development of his “Four Reasons to Live” framework, and how understanding a patient’s purpose influences outcomes beyond the operating room. Our conversation also explores humanism in healthcare, the role of technology in restoring meaningful patient‑provider connections, and how innovation can support both patients and care teams. Tune in for a thoughtful discussion on purpose and the future of transplant care!

Recorded at the 2026 SCbio Annual Conference in Charleston, Heather and Matthew welcome Ken Webb, Professor of Bioengineering at Clemson University and Co‑Founder and President of NeuroHope Therapeutics. We have an exciting conversation about how Ken’s research team is developing and commercializing novel drug‑delivery technologies aimed at treating central nervous system trauma, including spinal cord and traumatic brain injuries. Ken also reflects on his journey as an academic entrepreneur, the role of SCbio and other partners in supporting early‑stage life sciences startups, and what he sees ahead for innovation at the intersection of science and patient care. Tune in for insights on cutting‑edge research with a life-changing impact.

Recorded live from the 2026 SCbio Annual Conference in Charleston, Heather and Lauren are joined by Daniel Grove, Director of Human Resources at Lonza, one of the world’s largest healthcare manufacturing organizations. Daniel offers insight into the unique workforce challenges facing life sciences manufacturing, from operating in a regulated environment to competing for top talent in a growing market. We also discuss strategies for building a future‑ready workforce through leadership development, culture, and a strong connection to purpose. Tune in for a thoughtful conversation on building teams that thrive in the life sciences industry.

Filmed at the 2026 SCbio Annual Conference in Charleston, Heather and Matthew welcome Gordon Maner, Partner at Frontline Healthcare Partners and CEO of AMB Wealth, for a conversation on private equity’s growing role in healthcare. Gordon shares his unconventional path into investing, the strategy behind Frontline’s focus on lower‑middle‑market healthcare services, and why culture matters as much as financial performance. We also dive into how his team evaluates risk, navigates regulatory complexity, and incorporates AI into investment decisions as healthcare continues to evolve. Tune in for an inside look at how seasoned investors are thinking about growth, value creation, and the future of healthcare services!

In this episode, we welcome back Kelli Ferry, recently promoted to Chief Legal Officer and Executive Vice President of Novant Health. Kelli shares how her role has evolved as Novant expands across the Southeast, offering insight into her leadership approach, how the legal department is adapting to organizational growth, and the system’s responsible use of AI in both legal and clinical settings. She also discusses how Novant is preparing for upcoming Medicaid changes and continuing to prioritize patient care and value‑based models. Tune in now for an inside look at leading a modern legal team in a fast‑growing healthcare system!